AO Indicators For Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) Touch 0.86432647

There are many factors that can affect the health of a company. This is one reason why stock trading can be extremely difficult at times. Because there are always so many things to take into consideration, it may be next to impossible to create a formula that will continually beat the market. Even after all the data has been scrutinized and the numbers have been crunched, the investor still has to make sense of the information and figure out what to do with it. Knowing how to use the information about publically traded companies can end up being the difference between handsome gains and devastating losses. 

Technical traders have many tools at their disposal when conducting stock research. One of those tools is the Exponential Moving Average or EMA. The EMA is similar to the simple moving average, but more weight is put on the newest data. Let’s look at some different EMA levels on shares of Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX):

10 day Exponential Moving Average: 5.23918127
20 day Exponential Moving Average: 4.99258375
30 day Exponential Moving Average: 4.84357076
50 day Exponential Moving Average: 4.73897032
100 day Exponential Moving Average: 4.74856949
200 day Exponential Moving Average: 4.80385148

Following trading action on shares of Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX), we see that the stock has moved -0.235 since the opening price of 5.47. So far, the stock has reached a high of 5.59 and dipped to a low of 5.15. The consensus rating on the stock is currently Buy, and today’s volume has been measured around 349433.

Tracking some stock ratings, we can see that the stock’s Moving Average Rating is currently pointing to a “Strong Buy”. Traders may be monitoring many different indicators in order to get a grasp of where the stock may be moving in the near future. Taking a look at the Oscillators rating, we note that the reading is pointing to a “Buy”.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Traders will take note of the 20 day Chaikin Money Flow indicator that is now at 0.20323943. The value of this indicator will fluctuate between 1 and -1. Traders may be watching when the CMF crosses zero. This cross might point to a bullish or bearish price reversal depending on which way it is moving crossing the zero line.

There are a number of different pivot points that traders can use when conducting stock analysis. Pivot points can be useful for traders looking to establish trading entry and exit points. Focusing on some popular one month pivots, we see that the Woodie pivot is currently at 4.73875. The Woodie support 1 pivot is 4.5625, and the Woodie resistance 1 pivot is 5.2175. The Camarilla one month pivot is presently 4.67166667. The one month Classic pivot is 4.67166667 and the Classic resistance 1 is 5.08333333 while the Classic support 1 pivot is measured at 4.42833333.

The Awesome Oscillator reading is currently 0.86432647 for on shares of Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX). Technical traders will watch the AO especially when it crosses above or below the zero line. A move above the line may signal a bullish scenario. A move below the zero line may indicate a bearish selling opportunity. The AO may prove to be a valuable tool for many momentum traders.

Taking a look at the Donchian Channels indicator, we note that the 20 day lower band is 4.26. The 20 day upper band is 5.63. This indicator was created by Richard Donchian, and traders follow these channels to help identify potential trading signals.

There are many factors that can affect the health of a company. This is one reason why stock trading can be extremely difficult at times. Because there are always so many things to take into consideration, it may be next to impossible to create a formula that will continually beat the market. Even after all the data has been scrutinized and the numbers have been crunched, the investor still has to make sense of the information and figure out what to do with it. Knowing how to use the information about publically traded companies can end up being the difference between handsome gains and devastating losses.